Improving Antibiotic Stewardship for Children With Respiratory Illness Presenting to Village Health Workers in Uganda
NCT05294510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1280
Last updated 2022-08-04
Summary
This is a stepped wedge, cluster randomized study of a clinical algorithm that includes point-of-care C-reactive protein testing to inform antibiotic treatment decisions by village health workers for children presenting with acute respiratory illness in the Bugoye sub-county of the Kasese District in southwestern Uganda.
The purpose of this study is to assess the impact of the algorithm on antibiotic use.
Conditions
- Respiratory Infections in Children
Interventions
- OTHER
-
STAR Sick Child Job Aid
The STAR Sick Child Job Aid is a modified ICCM protocol that includes the addition of a point-of-care C-reactive protein (CRP) test to inform antibiotic treatment decisions for children presenting with febrile acute respiratory illness who do not have any danger signs. If CRP ≥ 40 mg/L, the village health worker (VHW) will dispense amoxicillin per local guidelines. If CRP \< 40 mg/L, the VHW will advise symptomatic care alone including acetaminophen for fever and additional fluids to maintain hydration.
Sponsors & Collaborators
-
Thrasher Research Fund
collaborator OTHER -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Emily J Ciccone, MD, MHS · University of North Carolina, Chapel Hill
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 2 Months
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-02
- Primary Completion
- 2022-05-30
- Completion
- 2022-05-30
Countries
- Uganda
Study Locations
More Related Trials
-
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
NCT01349192 ·Status: TERMINATED ·Phase: PHASE2
-
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
NCT04503252 ·Status: COMPLETED
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial
NCT00100386 ·Status: COMPLETED ·Phase: NA
-
Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)
NCT05764876 ·Status: COMPLETED ·Phase: PHASE3
-
WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8
NCT01659437 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
NCT02223520 ·Status: COMPLETED ·Phase: NA
-
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
NCT00622882 ·Status: UNKNOWN ·Phase: NA
-
Trial of MRSA Polymerase Chain Reaction for Pneumonia
NCT02660554 ·Status: COMPLETED ·Phase: NA
-
Staphylococcus Aureus Bacteraemia (SAB)-Support-Study
NCT06249451 ·Status: COMPLETED ·Phase: NA
-
An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis
NCT02454205 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
NCT01105767 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study
NCT02169557 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication
NCT03490123 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
NCT02284555 ·Status: COMPLETED ·Phase: PHASE4
-
BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANA
NCT00321178 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting
NCT01053598 ·Status: COMPLETED
-
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
NCT04618198 ·Status: UNKNOWN ·Phase: PHASE3
-
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
NCT03025789 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.
NCT02357966 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
NCT00518076 ·Status: UNKNOWN
-
Human Immunity Against Staphylococcus Aureus Skin Infection
NCT02262819 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility and Usability of COVID-19 Antigen RDTs in Uganda
NCT05630300 ·Status: COMPLETED ·Phase: NA
-
Adjunctive Linezolid for the Treatment of Tuberculous Meningitis
NCT04021121 ·Status: COMPLETED ·Phase: PHASE2